Transplantation for idiopathic pulmonary arterial hypertension: Improvement in the lung allocation score era

Circulation

Volumn 127, Issue 25, 2013, Pages 2503-2513

  Schaffer, Justin M ^a   Singh, Steve K ^a   Joyce, David L ^a   Reitz, Bruce A ^a   Robbins, Robert C ^a   Zamanian, Roham T ^a   Mallidi, Hari R ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

hypertension; hypertension, pulmonary; statistics; survival; transplantation

Indexed keywords

ADULT; ALGORITHM; ARTICLE; COMORBIDITY; ESSENTIAL HYPERTENSION; FEMALE; HEART LUNG TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECIPIENT; REGISTER; RETROSPECTIVE STUDY; SURVIVAL; TIME;

HYPERTENSION; HYPERTENSION, PULMONARY; STATISTICS; SURVIVAL; TRANSPLANTATION;

ADULT; ALGORITHMS; FEMALE; HEALTH CARE RATIONING; HEART TRANSPLANTATION; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; KAPLAN-MEIER ESTIMATE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; WAITING LISTS;

EID: 84879530758     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.001080     Document Type: Article

References (46)

1. Rubin LJ. Primary pulmonary hypertension. N Engl J Med. 1997;336:111-117.
2. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT, Levy PS, Pietra GG, Reid LM, Reeves JT, Rich S, Vreim CE, Williams GW, Wu M. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med. 1991;115:343-349.
3. Corris PA. Alternatives to lung transplantation: treatment of pulmonary arterial hypertension. Clin Chest Med. 2011;32:399-410.
4. Galiè N, Manes A, Negro L, Palazzini M, Bacchi-Reggiani ML, Branzi A. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J. 2009;30:394-403.
5. McGoon MD, Miller DP. REVEAL: a contemporary US pulmonary arterial hypertension registry. Eur Respir Rev. 2012;21:8-18.
6. Chung L, Liu J, Parsons L, Hassoun PM, McGoon M, Badesch DB, Miller DP, Nicolls MR, Zamanian RT. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. Chest. 2010;138:1383-1394.
7. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J, Harrington RA, Anderson JL, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Grines CL, Hlatky MA, Jacobs AK, Kaul S, Lichtenberg RC, Lindner JR, Moliterno DJ, Mukherjee D, Pohost GM, Rosenson RS, Schofield RS, Shubrooks SJ, Stein JH, Tracy CM, Weitz HH, Wesley DJ; ACCF/AHA. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009;119:2250-2294.
8. Stringham R, Shah NR. Pulmonary arterial hypertension: an update on diagnosis and treatment. Am Fam Physician. 2010;82:370-377.
9. Levine SM, Gibbons WJ, Bryan CL, Walling AD, Brown RW, Bailey SR, Cronin T, Calhoon JP, Trinkle JK, Jenkinson SG. Single lung transplantation for primary pulmonary hypertension. Chest. 1990;98:1107-1115.
10. Pasque MK, Trulock EP, Cooper JD, Triantafillou AN, Huddleston CB, Rosenbloom M, Sundaresan S, Cox JL, Patterson GA. Single lung transplantation for pulmonary hypertension: single institution experience in 34 patients. Circulation. 1995;92:2252-2258.
11. Gammie JS, Keenan RJ, Pham SM, McGrath MF, Hattler BG, Khoshbin E, Griffith BP. Single-versus double-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg. 1998;115:397-402.
12. Christie JD, Edwards LB, Kucheryavaya AY, Aurora P, Dobbels F, Kirk R, Rahmel AO, Stehlik J, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report-2010. J Heart Lung Transplant. 2010;29:1104-1118.
13. Conte JV, Borja MJ, Patel CB, Yang SC, Jhaveri RM, Orens JB. Lung transplantation for primary and secondary pulmonary hypertension. Ann Thorac Surg. 2001;72:1673-1679.
14. Toyoda Y, Thacker J, Santos R, Nguyen D, Bhama J, Bermudez C, Kormos R, Johnson B, Crespo M, Pilewski J, Teuteberg J, Alvarez R, Mathier M, McNamara D, McCurry K, Zenati M, Hattler B. Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension. Ann Thorac Surg. 2008;86:1116-1122.
15. Fadel E, Mercier O, Mussot S, Leroy-Ladurie F, Cerrina J, Chapelier A, Simonneau G, Dartevelle P. Long-term outcome of double-lung and heart-lung transplantation for pulmonary hypertension: a comparative retrospective study of 219 patients. Eur J Cardiothorac Surg. 2010;38:277-284.
16. Whyte RI, Robbins RC, Altinger J, Barlow CW, Doyle R, Theodore J, Reitz BA. Heart-lung transplantation for primary pulmonary hypertension. Ann Thorac Surg. 1999;67:937-941.
17. Deuse T, Sista R, Weill D, Tyan D, Haddad F, Dhillon G, Robbins RC, Reitz BA. Review of heart-lung transplantation at Stanford. Ann Thorac Surg. 2010;90:329-337.
18. Egan TM, Murray S, Bustami RT, Shearon TH, McCullough KP, Edwards LB, Coke MA, Garrity ER, Sweet SC, Heiney DA, Grover FL. Development of the new lung allocation system in the United States. Am J Transplant. 2006;6(pt 2):1212-1227.
19. Chen H, Shiboski SC, Golden JA, Gould MK, Hays SR, Hoopes CW, De Marco T. Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med. 2009;180:468-474.
20. Stuart EA. Matching methods for causal inference: a review and a look forward. Stat Sci. 2010;25:1-21.
21. Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods. 2002;7:147-177.
22. Schafer JL. Analysis of Incomplete Multivariate Data. London, United Kingdom: Chapman & Hall; 1997.
23. Graham JW, Olchowski AE, Gilreath TD. How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev Sci. 2007;8:206-213.
24. Rubin DB. Multiple imputation after 18+ years (with discussion). J Am Stat Assoc. 1996;91:473-489.
25. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
26. Mitra R, Reiter JP. A comparison of two methods of estimating propensity scores after multiple imputation. Stat Methods Med Res. June 11, 2012. doi:10.1177/0962280212445945. http://smm.sagepub.com/content/early/2012/06/11/ 0962280212445945.long. Accessed April 30, 2013.
27. Rosenbaum PR, Rubin DB. Constructing control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39:33-38.
28. Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med. 2008;27:2037-2049.
29. Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics. 1978;34:541-554.
30. Pepe MS, Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med. 1993;12:737-751.
31. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
32. Breslow NE. A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship. Biometrika. 1970;57:579-594.
33. Cox DR. Regression models and life-tables. J R Stat Soc Series B Stat Methodol. 1972;34:187-220.
34. Fisher LD, Lin DY. Time-dependent covariates in the Cox proportionalhazards regression model. Annu Rev Public Health. 1999;20:145-157.
35. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43-46.
36. Weiss ES, Allen JG, Meguid RA, Patel ND, Merlo CA, Orens JB, Baumgartner WA, Conte JV, Shah AS. The impact of center volume on survival in lung transplantation: an analysis of more than 10,000 cases. Ann Thorac Surg. 2009;88:1062-1070.
37. Thabut G, Christie JD, Kremers WK, Fournier M, Halpern SD. Survival differences following lung transplantation among US transplant centers. JAMA. 2010;304:53-60.
38. Benza RL, Miller DP, Frost A, Barst RJ, Krichman AM, McGoon MD. Analysis of the lung allocation score estimation of risk of death in patients with pulmonary arterial hypertension using data from the REVEAL Registry. Transplantation. 2010;90:298-305.
39. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaïci A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Cottin V, Degano B, Jaïs X, Montani D, Souza R, Simonneau G. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010;122:156-163.
40. Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, Liou TG, McGoon MD. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010;122:164-172.
41. Kawut SM, Al-Naamani N, Agerstrand C, Rosenzweig EB, Rowan C, Barst RJ, Bergmann S, Horn EM. Determinants of right ventricular ejection fraction in pulmonary arterial hypertension. Chest. 2009;135:752-759.
42. Kawut SM, Barr RG, Lima JA, Praestgaard A, Johnson WC, Chahal H, Ogunyankin KO, Bristow MR, Kizer JR, Tandri H, Bluemke DA. Right ventricular structure is associated with the risk of heart failure and cardiovascular death: the Multi-Ethnic Study of Atherosclerosis (MESA)-right ventricle study. Circulation. 2012;126:1681-1688.
43. Weiss ES, Allen JG, Patel ND, Russell SD, Baumgartner WA, Shah AS, Conte JV. The impact of donor-recipient sex matching on survival after orthotopic heart transplantation: analysis of 18 000 transplants in the modern era. Circ Heart Fail. 2009;2:401-408.
44. Allen JG, Weiss ES, Merlo CA, Baumgartner WA, Conte JV, Shah AS. Impact of donor-recipient race matching on survival after lung transplantation: analysis of over 11,000 patients. J Heart Lung Transplant. 2009;28:1063-1071.
45. Mulligan MS, Shearon TH, Weill D, Pagani FD, Moore J, Murray S. Heart and lung transplantation in the United States, 1997-2006. Am J Transplant. 2008;8(pt 2):977-987.
46. Thabut G, Fournier M. Assessing survival benefits from lung transplantation. Rev Mal Respir. 2011;28:e1-e6.